Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to Obstetrics & Gynecology

MCN: The American Journal of Maternal/Child Nursing

Social Interactions and Institutional Structures that Influence 24-Hour Rooming-in for New Mothers and Newborns in the Hospital Setting

The article explores social interactions and institutional structures impacting the consistent practice of 24-hour rooming-in for new mothers and newborns in hospitals. Researchers employed an institutional ethnographic design, gathering data through semistructured interviews and unit observations from February 2020 to June 2021. Seven mother-baby nurses participated in interviews. Additionally, three on-unit observations lasting 2 hours each took place. From the collected data, the researchers unearthed a shared sentiment: “Baby-Friendly” practices don’t always equate to being “mother-friendly.” Three primary social interaction themes surfaced from the data analysis: viewing the mother as a patient, managing expectations, and inconsistent practices. The nurses’ perspectives revealed the complexity of managing maternal care while juggling newborn demands. Discrepancies in methods highlighted the need for standardized practices to maintain consistency across care provision. The analysis also identified three significant institutional factors that affect 24-hour rooming-in: rates of labor induction and cesarean births, nurse staffing, and nursery use monitoring. Labor induction and cesarean births often disrupt the smooth transition to rooming-in. Limited nurse staffing presents challenges in managing both mother and baby needs, while nursery use monitoring practices influence rooming-in implementation. The article’s findings provide critical insights into the daily organization and experience of 24-hour rooming-in from a […]

Hospitalist May 30th 2023

Pain Medicine News

New AANA Obstetric Guidelines Prioritize Addressing Gaps in Health Equity

Anesthesiology May 24th 2023

Oncology Nurse Advisor

Permissive Cardiotoxicity Strategy Improves Completion of Trastuzumab Cycles in HER2-Positive Breast Cancer

Permissive cardiotoxicity strategy could enhance trastuzumab treatment outcomes in HER2-positive breast cancer patients, despite requiring more research into its long-term safety. A study conducted at McMaster University and published in The Oncologist explored the feasibility of a permissive cardiotoxicity strategy in patients with HER2-positive breast cancer undergoing trastuzumab treatment. Although trastuzumab significantly improves outcomes in these patients, up to 4% of them may experience cardiac dose-limiting toxicity (cDLT), resulting in therapy discontinuation, which can negatively impact patient outcomes. The researchers employed a retrospective cohort study of 51 patients who had been referred to the cardio-oncology service between January 2016 and May 2021 for left ventricular dysfunction after trastuzumab administration. Notably, a permissive cardiotoxicity strategy was applied, which allows the continuation of trastuzumab therapy while closely monitoring mild to moderate cardiotoxicity. The primary outcomes for this study were left ventricular (LV) function and completion of an entire course of trastuzumab. Astonishingly, 92% of patients (47 out of 51) were able to complete their full course of HER2-targeted therapy without experiencing cDLT. However, 6% developed cDLT during trastuzumab treatment, and even after discontinuation, they were more likely to experience persistent cardiotoxicity. Interestingly, despite most patients regaining their LV function post-treatment, 14% persisted […]

Obstetrics & Gynecology May 22nd 2023

Northwestern Medicine

Feinberg Again Ranks Among Top Medical Schools in the Nation

Anesthesiology May 17th 2023

MDLinx

Updates to Mammography Regulations: What Your Patients Need to Know

Obstetrics & Gynecology May 16th 2023

Oncology Learning Network

Efficacy and Safety of Chemoradiation for Patients with Stage IB3 Cervical Cancer

Obstetrics & Gynecology May 8th 2023